RxDoctor Payments Data

Natalia Morris, PA

Physician Assistant · la Quinta, CANPI 1467708545

Payments from drug & device makers

$2,363in general payments, 2019–2025

Across 120 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$430
  • Ardelyx, Inc.$172
  • Johnson & Johnson$122
  • Takeda Pharmaceuticals U.S.A., Inc.$119
  • Sanofi$57
  • plus $189 from 7 others

What the payments were for

  • Food & beverage$2,363100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,363 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$34,729
Medicare patients
216
Services billed
318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide69$54,476
CreonLipase/Protease/Amylase36$51,231
MotegrityPrucalopride Succinate21$17,645
TrulancePlecanatide12$8,430
MovantikNaloxegol Oxalate16$6,101
Lubiprostone23$4,165
Pantoprazole Sodium217$1,822
Omeprazole93$1,469
Sucralfate21$1,210
Famotidine69$1,150
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl83$1,016
Dicyclomine Hcl41$925
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates15$893
Lactulose26$436
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl20$330

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$1,274$105,707105 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$119$17,64521 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$430$8,43012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in la Quinta

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →